Higher parity and shorter breastfeeding duration

Cancer

Volumn 116, Issue 21, 2010, Pages 4933-4943

  Shinde, Shivani S ^a,b   Forman, Michele R ^a,b   Kuerer, Henry M ^c   Yan, Kai ^a   Peintinger, Florentia ^a,c   Hunt, Kelly K ^c   Hortobagyi, Gabriel N ^a   Pusztai, Lajos ^a   Symmans, W Fraser ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Breastfeeding; Ethnicity; Lactation; Parity; Progenitor; Triple negative

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BREAST CANCER; BREAST FEEDING; CANCER INVASION; CANCER RISK; CASE STUDY; ETHNICITY; FAMILY HISTORY; FEMALE; HISPANIC; HORMONE SUBSTITUTION; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; NULLIPARA; PARITY; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST FEEDING; BREAST NEOPLASMS; FEMALE; HUMANS; MENARCHE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; PARITY; PHENOTYPE; PREGNANCY; RISK FACTORS; TIME FACTORS;

EID: 78249236887     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25443     Document Type: Article

References (38)

1. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98: 10869 -10874.
2. Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008; 26: 1275 -1281.
3. Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res. 2005; 11: 5678 -5685.
4. Reis-Filho JS, Tutt AN,. Triple negative tumours: a critical review. Histopathology. 2008; 52: 108 -118.
5. Schneider BP, Winer EP, Foulkes WD, et al. Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008; 14: 8010 -8018.
6. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295: 2492 -2502.
7. Millikan RC, Newman B, Tse CK, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008; 109: 123 -139.
8. Symmans WF, Fiterman DJ, Anderson SK, et al. A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. Endocr Relat Cancer. 2005; 12: 1059 -1069.
9. Kwan ML, Kushi LH, Weltzien E, et al. Epidemiology of breast cancer subtypes in 2 prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11: R31.
10. Russo J, Russo IH,. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev. 1994; 3: 353 -364.
11. Russo J, Moral R, Balogh GA, Mailo D, Russo IH,. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005; 7: 131 -142.
12. Russo J, Balogh G, Mailo D, Russo PA, Heulings R, Russo IH,. The genomic signature of breast cancer prevention. Recent Results Cancer Res. 2007; 174: 131 -150.
13. Wagner KU, Smith GH,. Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia. 2005; 10: 25 -36.
14. Lamb R, Harrison H, Clarke RB,. Mammary development, carcinomas and progesterone: role of Wnt signalling. Ernst Schering Found Symp Proc. 2007;(1): 1 -23.
15. Howard B, Ashworth A,. Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet. 2006; 2: e112.
16. Bocker W, Moll R, Poremba C, et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest. 2002; 82: 737 -746.
17. Symmans WF,. Breastfeeding history and undifferentiated breast cancer. Published Research Proposal BCTR0600984, Susan G. Komen for The Cure, 2005. Available at:.
18. Lipworth L, Bailey LR, Trichopoulos D,. History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst. 2000; 92: 302 -312.
19. Purwanto H, Sadjimin T, Dwiprahasto I,. Lactation and the risk of breast cancer. Gan To Kagaku Ryoho. 2000; 27 (suppl 2): 474 -481.
20. Lambe M, Hsieh CC, Chan HW, Ekbom A, Trichopoulos D, Adami HO,. Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat. 1996; 38: 305 -311.
21. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002; 360: 187 -195.
22. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME,. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004; 13: 1558 -1568.
23. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG,. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000; 151: 703 -714.
24. Ursin G, Bernstein L, Lord SJ, et al. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005; 93: 364 -371.
25. Britton JA, Gammon MD, Schoenberg JB, et al. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. Am J Epidemiol. 2002; 156: 507 -516.
26. Yoo KY, Tajima K, Miura S, et al. Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol. 1997; 146: 307 -314.
27. O'Campo P, Faden RR, Gielen AC, Wang MC,. Prenatal factors associated with breastfeeding duration: recommendations for prenatal interventions. Birth. 1992; 19: 195 -201.
28. Kruse L, Denk CE, Feldman-Winter L, Rotondo FM,. Longitudinal patterns of breastfeeding initiation. Matern Child Health J. 2006; 10: 13 -18.
29. Li R, Scanlon KS, Serdula MK,. The validity and reliability of maternal recall of breastfeeding practice. Nutr Rev. 2005; 63: 103 -110.
30. Launer LJ, Forman MR, Hundt GL, et al. Maternal recall of infant feeding events is accurate. J Epidemiol Community Health. 1992; 46: 203 -206.
31. Promislow JH, Gladen BC, Sandler DP,. Maternal recall of breastfeeding duration by elderly women. Am J Epidemiol. 2005; 161: 289 -296.
32. Stuebe AM, Willett WC, Xue F, Michels KB,. Lactation and incidence of premenopausal breast cancer: a longitudinal study. Arch Intern Med. 2009; 169: 1364 -1371.
33. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V,. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007; 109: 1721 -1728.
34. Ryan AS,. The resurgence of breastfeeding in the United States. Pediatrics. 1997; 99: E12.
35. Ryan AS, Wenjun Z, Acosta A,. Breastfeeding continues to increase into the new millennium. Pediatrics. 2002; 110: 1103 -1109.
36. Li R, Darling N, Maurice E, Barker L, Grummer-Strawn LM,. Breastfeeding rates in the United States by characteristics of the child, mother, or family: the 2002 National Immunization Survey. Pediatrics. 2005; 115: e31 -e37.
37. Centers for Disease Control and Prevention (CDC). Racial and socioeconomic disparities in breastfeeding-United States, 2004. MMWR Morb Mortal Wkly Rep. 2006; 55: 335 -339.
38. Hausauer AK, Keegan TH, Chang ET, Clarke CA,. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res. 2007; 9: R90.